{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:55:46Z","timestamp":1767182146903,"version":"build-2238731810"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T00:00:00Z","timestamp":1207094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001908","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T16:49:20Z","timestamp":1207068560000},"page":"e1908","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer"],"prefix":"10.1371","volume":"3","author":[{"given":"Kelly H.","family":"Salter","sequence":"first","affiliation":[]},{"given":"Chaitanya R.","family":"Acharya","sequence":"additional","affiliation":[]},{"given":"Kelli S.","family":"Walters","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Redman","sequence":"additional","affiliation":[]},{"given":"Ariel","family":"Anguiano","sequence":"additional","affiliation":[]},{"given":"Katherine S.","family":"Garman","sequence":"additional","affiliation":[]},{"given":"Carey K.","family":"Anders","sequence":"additional","affiliation":[]},{"given":"Sayan","family":"Mukherjee","sequence":"additional","affiliation":[]},{"given":"Holly K.","family":"Dressman","sequence":"additional","affiliation":[]},{"given":"William T.","family":"Barry","sequence":"additional","affiliation":[]},{"given":"Kelly P.","family":"Marcom","sequence":"additional","affiliation":[]},{"given":"John","family":"Olson","sequence":"additional","affiliation":[]},{"given":"Joseph R.","family":"Nevins","sequence":"additional","affiliation":[]},{"given":"Anil","family":"Potti","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2008,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1073\/pnas.191368598","article-title":"Chemosensitivity prediction by transcriptional profiling.","volume":"98","author":"JE Staunton","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.2005.04.8678","article-title":"Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening\u2013a report from the American Society of Clinical Oncology.","volume":"24","author":"RS Herbst","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1200\/JCO.2001.19.6.1734","article-title":"Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results.","volume":"19","author":"OS Breathnach","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm1491","article-title":"Genomic signatures to guide the use of chemotherapeutics.","volume":"12","author":"A Potti","year":"2006","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrg2137","article-title":"Mining gene expression profiles: expression signatures as cancer phenotypes.","volume":"8","author":"JR Nevins","year":"2007","journal-title":"Nat Rev Genet"},{"key":"ref6","article-title":"Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994\/BIG 00-01 clinical trial.","author":"H Bonnefoi","year":"2007","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1200\/JCO.2007.11.0593","article-title":"Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.","volume":"25","author":"DS Hsu","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","article-title":"Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.","volume":"26","author":"TC Chang","year":"2007","journal-title":"Mol Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","article-title":"p53-mediated activation of miRNA34 candidate tumor-suppressor genes.","volume":"17","author":"GT Bommer","year":"2007","journal-title":"Curr Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network.","volume":"447","author":"L He","year":"2007","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","article-title":"Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.","volume":"26","author":"N Raver-Shapira","year":"2007","journal-title":"Mol Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.4161\/cc.6.13.4436","article-title":"Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.","volume":"6","author":"V Tarasov","year":"2007","journal-title":"Cell Cycle"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.1999.17.3.1061","article-title":"Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death.","volume":"17","author":"C Dumontet","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1349-7006.2007.00531.x","article-title":"Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.","volume":"98","author":"H Tagawa","year":"2007","journal-title":"Cancer Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","article-title":"Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.","volume":"6","author":"SM Park","year":"2007","journal-title":"Cell Cycle"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","article-title":"Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.","volume":"130","author":"F Meng","year":"2006","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa071167","article-title":"HER2 and response to paclitaxel in node-positive breast cancer.","volume":"357","author":"DF Hayes","year":"2007","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy.","volume":"11","author":"R Rouzier","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ctrv.2006.10.001","article-title":"The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours.","volume":"33","author":"MS Mano","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(03)14023-8","article-title":"Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.","volume":"362","author":"JC Chang","year":"2003","journal-title":"Lancet"},{"key":"ref21","first-page":"3910","article-title":"Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.","volume":"8","author":"GH Yoo","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.","volume":"99","author":"GA Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets.","volume":"103","author":"S Volinia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies.","volume":"439","author":"AH Bild","year":"2006","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: A Language for Data Analysis and Graphics.","volume":"5","author":"RaG, RE Ihaka","year":"1996","journal-title":"Journal of Computational and Graphical Statistics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1158\/1078-0432.CCR-07-0809","article-title":"Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer.","volume":"13","author":"L Pusztai","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0.","volume":"38","author":"M Reich","year":"2006","journal-title":"Nat Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/ijc.21570","article-title":"Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.","volume":"118","author":"B Gyorffy","year":"2006","journal-title":"Int J Cancer"}],"updated-by":[{"DOI":"10.1371\/annotation\/8f94e479-4161-43a0-a28c-4c0460bb89a4","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000},"record-id":"1998"},{"DOI":"10.1371\/annotation\/8f94e479-4161-43a0-a28c-4c0460bb89a4","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:20:26Z","timestamp":1738131626000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001908"}},"subtitle":[],"editor":[{"given":"Toru","family":"Ouchi","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2008,4,2]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001908","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,2]]}}}